Clinical Trial Update: Tenofovir Versus Lamivudine for Patients of Chronic Hepatitis B With Severe Acute Exacerbation [Phase 3]

View source ↗

Summary

This update describes a Phase 3 clinical trial comparing tenofovir disoproxil fumarate to lamivudine in patients with chronic hepatitis B experiencing severe ac…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Hepatitis B

Drugs mentioned

• Epivir (Lamivudine)
• Viread (tenofovir disoproxil fumarate)

Snippet

Sponsor: Kaohsiung Veterans General Hospital. | Conditions: Chronic HBV With Severe Exacerbation | Phase 3 | Status: UNKNOWN